Based on these observations, it could be proposed that lowered PHD2 oxidation might impair its catalytic activity, thus leading to the elevation of HIF-1a protein abundance and the enhancement of target gene expression to promote pancreatic cancer development. The gene discussed is EGLN1; the disease is pancreatic neoplasm.